Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?
Joint Authors
Larsen, Matthias Ploug
Torekov, Signe Sørensen
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-13, 13 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-09-10
Country of Publication
Egypt
No. of Pages
13
Main Subjects
Abstract EN
Background.
The incretin effect is impaired in patients with type 2 diabetes.
Aim.
To assess the relation between the incretin hormone GLP-1 and the prediabetic subtypes: impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and the combined IFG/IGT to investigate whether a low GLP-1 response may be a predictor of prediabetes in adults.
Method.
298 articles were found using a broad search phrase on the PubMed database and after the assessment of titles and abstracts 19 articles were included.
Results and Discussion.
Studies assessing i-IFG/IFG and i-IGT/IGT found both increased, unaltered, and reduced GLP-1 levels.
Studies assessing IFG/IGT found unaltered or reduced GLP-1 levels.
When assessing the five studies with the largest sample size, it clearly suggests a decreased GLP-1 response in IFG/IGT subjects.
Several other factors (BMI, glucagon, age, and nonesterified fatty acids (NEFA)), including medications (metformin), may also influence the secretion of GLP-1.
Conclusion.
This review suggests that the GLP-1 response is a variable in prediabetes possibly due to a varying GLP-1-secreting profile during the development and progression of type 2 diabetes or difference in the measurement technique.
Longitudinal prospective studies are needed to assess whether a reduced GLP-1 response is a predictor of diabetes.
American Psychological Association (APA)
Larsen, Matthias Ploug& Torekov, Signe Sørensen. 2017. Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?. Journal of Diabetes Research،Vol. 2017, no. 2017, pp.1-13.
https://search.emarefa.net/detail/BIM-1174719
Modern Language Association (MLA)
Larsen, Matthias Ploug& Torekov, Signe Sørensen. Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?. Journal of Diabetes Research No. 2017 (2017), pp.1-13.
https://search.emarefa.net/detail/BIM-1174719
American Medical Association (AMA)
Larsen, Matthias Ploug& Torekov, Signe Sørensen. Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?. Journal of Diabetes Research. 2017. Vol. 2017, no. 2017, pp.1-13.
https://search.emarefa.net/detail/BIM-1174719
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1174719